Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) was the target of a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 1,180,000 shares, a decrease of 18.6% from the September 15th total of 1,450,000 shares. Approximately 1.1% of the shares of the stock are […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week high during trading on Friday after Royal Bank of Canada raised their price target on the stock from $833.00 to $847.00. Royal Bank of Canada currently has a sector perform rating on the stock. Regeneron Pharmaceuticals traded as high as $851.78 and […]
CENTRAL TRUST Co lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 26.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,700 shares of the biopharmaceutical company’s stock after selling 981 shares during the quarter. CENTRAL […]
State of Michigan Retirement System reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,597 shares of the biopharmaceutical company’s stock after selling 300 shares during the quarter. State […]
Institute for Wealth Management LLC. lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.8% during the second quarter, HoldingsChannel reports. The firm owned 921 shares of the biopharmaceutical company’s stock after selling 67 shares during the quarter. Institute for Wealth Management LLC.’s holdings in Regeneron Pharmaceuticals were worth $662,000 as of […]